Samples should arrive within the laboratory within 72 hours of collection.
If sample cannot be sent immediately after bleeding, keep in 4 degree fridge and send as soon as possible.
FIP1L1-PDGFRA fusion gene is present in approximately 10-15% of patients with hypereosinophilic syndrome (HES). Since PDGFRA is a therapeutic target of tyrosine kinase inhibitor imatinib, patient with FIP1L1-PDGFRA fusion gene are dramatically sensitive to treatment with imatinib.
Contact HODS Molecular Biology Lab for further enquiries on Ext. 4326.
